Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate
about
Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and managementSelective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispeciesCurrent progress in the development of a prophylactic vaccine for HIV-1.Vaccine protection against feline immunodeficiency virus: setting the challenge.2008 American Association of Feline Practitioners' feline retrovirus management guidelines.Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom.AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogensAn investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virusFeline immunodeficiency virus (FIV) neutralization: a reviewFirst Molecular Characterization of Feline Immunodeficiency Virus in Domestic Cats from Mainland China.Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus.Advances in FIV vaccine technology.A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.Feline immunodeficiency virus model for designing HIV/AIDS vaccines.Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.A door-to-door prevalence study of feline immunodeficiency virus in an Australian suburb.Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodiesFeline leukemia and feline immunodeficiency virus in Canada - A comment.Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.Feline immunodeficiency virus subtypes in domestic cats in New Zealand.Molecular subtyping of feline immunodeficiency virus from domestic cats in Australia.Applications of the FIV Model to Study HIV Pathogenesis.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
P2860
Q26829717-8ACC6CA6-156F-4B1F-B4AB-CE11C49EC0BFQ27318192-C99FE608-54F6-4F4C-A4DE-49D9A23DAFC1Q34502108-154D2C26-7C76-4ACD-93A7-FE7545D75D75Q34575552-63595F03-E394-4EAF-B22D-51A7E6094902Q34775753-0953F5FB-4623-4D8A-9B81-DFC88E0CEDE9Q35012759-266A0F18-1027-4887-8A4E-677C247B36B2Q35024266-757113A9-3B76-4E16-855A-C3B2F33747ECQ35109028-3927F339-2624-4A7E-A695-C8E7F0BE5602Q35491705-0C10B975-C64D-4127-B1D4-83088B21DC7CQ36255380-1FEAD5A1-1FB5-4FBE-B823-42109E76A7F6Q36497644-16E4E7D4-8A8F-4DEB-8D6E-95519368D482Q36634847-18627D69-4EA6-4873-B47F-0DB9FECC7463Q36926701-60F432FE-E0B5-49CF-AF72-FC2D03EE0ED5Q37704546-C4FCD4C5-38B7-442C-A876-C1E8B14E6822Q38113162-305FC4FB-9B3D-4AFE-9758-A9AE21BAA269Q40115803-1A08F4CE-9BA4-4040-A114-3AB2BCB0B8BDQ42257512-B9937D6C-20B3-44ED-B8FD-B395A79790FDQ43013440-B9C65BA3-00EF-43D9-94C8-A9CB1C469327Q45378493-6FDA4E47-A58A-485C-A6BB-F7C1E69D05BDQ45398836-861F8AA6-E3BF-43E8-9C0D-D0294EC3E616Q45417428-BB366026-32DB-49AF-B2BD-41992C152771Q52574472-5E50AF50-DE08-4AEA-A180-F92F1A336EB3Q53686365-129416D0-095A-4006-ABF5-215C14A2E566
P2860
Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@ast
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@en
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@nl
type
label
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@ast
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@en
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@nl
prefLabel
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@ast
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@en
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@nl
P2093
P1476
Dual-subtype FIV vaccine (Fel- ...... rologous subtype B FIV isolate
@en
P2093
James Coisman
James Coleman
Janet K Yamamoto
Taishi Tanabe
P356
10.1016/J.JFMS.2004.08.005
P407
P577
2005-02-01T00:00:00Z